Skip to content

Clinical trials

Renal Insufficiency, Chronic trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Renal Insufficiency, Chronic Phase: Not applicable Clear all

1,027 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20046
20058
200610
200710
200823
200923
201017
201123
201233
201333
201440
201547
201649
201758
201848
201953
202046
202168
202259
202376
202482
2025101
2026101

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed537
Unknown status145
Recruiting126
Not yet recruiting89
Terminated52
Active, not recruiting45
Withdrawn17
Enrolling by invitation16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Universidade Federal Fluminense18
Duke University15
University of Calgary13
University of California, San Francisco13
VA Office of Research and Development10
Brigham and Women's Hospital9
University of Pennsylvania9
Cairo University8
Centre Hospitalier Universitaire de Nice8
Universitaire Ziekenhuizen KU Leuven8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Renal Insufficiency, Chronic1,027
Kidney Failure, Chronic117
Hypertension91
Diabetes Mellitus74
Kidney Diseases60
Diabetes Mellitus, Type 247
Renal Insufficiency43
Cardiovascular Diseases41
Heart Failure34
Inflammation29

Trials

Showing 26 to 50 of 1,027. Each trial links to its page on Pharma Observatory.

927 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.